Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase NA 7Phase 3 3

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Breast 3Plasma cell 2Lymphoid 2Head & Neck 2Gynecologic 2Gastrointestinal 1

Conditions

Breast Neoplasms 1128Triple Negative Breast Neoplasms 85Neoplasm Metastasis 62Neoplasms 40Breast Neoplasms, Male 20Prostatic Neoplasms 19Carcinoma, Intraductal, Noninfiltrating 19Neutropenia 18HER2-positive Breast Cancer 17Breast Carcinoma In Situ 17Pain 16Carcinoma, Ductal, Breast 16Hot Flashes 15Lung Neoplasms 14Inflammatory Breast Neoplasms 14Breast Diseases 14Brain Neoplasms 14Osteoporosis 13Multiple Myeloma 13Advanced Breast Cancer 13Recurrence 12Ovarian Neoplasms 12Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Ovarian Epithelial 11Testicular Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Mantle-Cell 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10

Interventions

Epirubicin 2Docetaxel 2Cyclophosphamide 2Carboplatin 2taxane 1pirarubicin 1pertuzumab 1pembrolizumab 1Trastuzumab 1Platinum 1Paclitaxel 1Capecitabine 1Antimetabolites 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Pathologic Complete Response × Breast × Clear all
NCT04335669 2025-09-12

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Lund University Hospital

Phase 3 Active not recruiting
325 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05474690 2024-02-26

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Henan Cancer Hospital

Phase 3 Withdrawn
Breast

Pathologic Complete Response, Breast Neoplasms

NCT02613026 2015-11-24

Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer

307 Hospital of PLA

Phase 3 Completed
104 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡